[{"NetIncomeLoss_1_Q1_USD":769600000.0,"CapitalizedContractCostAmortization_1_Q1_USD":3500000.0,"AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0_Q1_USD":-138400000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"DeferredRevenueRevenueRecognized1_1_Q1_USD":152300000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":500000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":220500000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":-88100000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":46800000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1508100000.0,"RestructuringReserveNoncurrent_0_Q1_USD":3000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-226500000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-132400000.0,"AccruedSalesCommissionCurrentAndNoncurrent_0_Q1_USD":36000000.0,"AssetsCurrent_0_Q1_USD":5638100000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":900000.0,"ContingentConsiderationClassifiedAsEquityFairValueDisclosure_0_Q1_USD":12800000.0,"ContractWithCustomerAssetGross_0_Q1_USD":579500000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.1,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.1,"ShareBasedCompensation_1_Q1_USD":28700000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-64600000.0,"Assets_0_Q1_USD":20417100000.0,"AmortizationOfDeferredSalesCommissions_1_Q1_USD":6900000.0,"Liabilities_0_Q1_USD":10374700000.0,"UnrecognizedTaxBenefits_0_Q1_USD":48900000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_1_Q1_USD":-66800000.0,"ContractWithCustomerLiability_0_Q1_USD":522300000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":82700000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":429800000.0,"RestructuringCharges_1_Q1_USD":19300000.0,"IncomeTaxesPaidNet_1_Q1_USD":40800000.0,"NotesPayable_0_Q1_USD":5800000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":67100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1890800000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_1_Q1_USD":3000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":2207500000.0,"EarningsPerShareBasic_1_Q1_USD":7.88,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":206900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":98500000.0,"PrepaidExpenseCurrent_0_Q1_USD":416800000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":5500000.0,"AccountsReceivableNetCurrent_0_Q1_USD":2323500000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":251700000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":31800000.0,"CommonStockValue_0_Q1_USD":9000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-5100000.0,"Revenues_1_Q1_USD":4161500000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":8700000.0,"InvestmentIncomeNet_1_Q1_USD":2400000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":0.0,"EffectiveIncomeTaxRateReconciliationTaxContingencies_1_Q1_pure":0.5,"GoodwillTranslationAndPurchaseAccountingAdjustments_1_Q1_USD":-46600000.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":422300000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":92100000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-16900000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":705000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":657800000.0,"IncreaseDecreaseInInventories_1_Q1_USD":4700000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-450100000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":5563400000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":6041500000.0,"CapitalizedContractCostNet_0_Q1_USD":14300000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":183900000.0,"OtherComprehensiveIncomeLossBeforeTax_1_Q1_USD":-63800000.0,"DeferredIncomeTaxesAndOtherAssetsCurrent_0_Q1_USD":20200000.0,"ForeignCurrencyContractsLiabilityFairValueDisclosure_0_Q1_USD":3000000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax_1_Q1_USD":0.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":34100000.0,"PaymentsToAcquireEquityMethodInvestments_1_Q1_USD":5500000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":16500000.0,"AmountOfDeferredCostsRelatedToLongTermContracts_0_Q1_USD":50300000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":4500000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":217500000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-3200000.0,"Goodwill_0_Q1_USD":7720500000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":2600000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":28100000.0,"CashSurrenderValueFairValueDisclosure_0_Q1_USD":93000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1157600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":97600000.0,"CostOfRevenue_1_Q1_USD":2562500000.0,"LiabilitiesCurrent_0_Q1_USD":3368700000.0,"DeferredRevenueCurrent_0_Q1_USD":540300000.0,"AccountsPayableCurrent_0_Q1_USD":621300000.0,"RestructuringReserveAccrualAdjustment1_1_Q1_USD":100000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2697000000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q1_USD":1000000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":2137300000.0,"RestructuringReserveCurrent_0_Q1_USD":6300000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":769600000.0,"RepaymentsOfOtherLongTermDebt_1_Q1_USD":375000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":212900000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q1_USD":85000000.0,"GrossProfit_1_Q1_USD":1599000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":3834000000.0,"LongTermDebtNoncurrent_0_Q1_USD":4920900000.0,"SeveranceCosts1_1_Q1_USD":4200000.0,"InterestExpense_1_Q1_USD":48500000.0,"NonoperatingIncomeExpense_1_Q1_USD":-36100000.0,"StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_0_Q1_shares":731500000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1_Q1_USD":-63800000.0,"EarningsPerShareDiluted_1_Q1_USD":7.82,"AssetImpairmentCharges_1_Q1_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":51900000.0,"BusinessExitCosts1_1_Q1_USD":15100000.0,"OtherComprehensiveIncomeLossTax_1_Q1_USD":800000.0,"CommonStockSharesAuthorized_0_Q1_shares":265000000.0,"OperatingIncomeLoss_1_Q1_USD":1057900000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q1_USD":-66800000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":21000000.0,"NotesPayableCurrent_0_Q1_USD":1900000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":68500000.0,"InventoryNet_0_Q1_USD":427500000.0,"RestructuringReserve_0_Q1_USD":9300000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-27800000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q1_USD":800000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":20417100000.0,"PreferredStockSharesAuthorized_0_Q1_shares":30000000.0,"UnbilledContractsReceivable_0_Q1_USD":579500000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":191300000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1_Q1_USD":-3000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-146700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":570000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":10171900000.0,"ProceedsFromSaleOfEquityMethodInvestments_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":200700000.0,"CommonStockSharesOutstanding_0_Q1_shares":97800000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":95400000.0,"GoodwillAcquiredDuringPeriod_1_Q1_USD":15600000.0,"FinitelivedIntangibleAssetsAcquired1_1_Q1_USD":17600000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":6300000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":486900000.0,"ProfitLoss_1_Q1_USD":770100000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":95100000.0,"StockholdersEquity_0_Q1_USD":10021500000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":705500000.0,"Ticker":"LH","CIK":"920148","name":"LABORATORY CORP OF AMERICA HOLDINGS","OfficialName":"Laboratory Corporation of America Holdings Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"25263722745.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"SP500","filed":"20210504"}]